Date published: 2026-5-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

PCDH8 Inhibitors

PCDH8, or Protocadherin 8, belongs to the protocadherin family of cell adhesion molecules and is primarily expressed in the nervous system. Protocadherins are known to play essential roles in mediating cell-cell adhesion and regulating processes such as neuronal development, synapse formation, and axonal guidance. PCDH8 inhibitors are designed to interact with the active site or binding domain of the PCDH8 protein, effectively inhibiting its function in cell adhesion and potentially influencing cellular processes dependent on PCDH8-mediated interactions.

Structurally, PCDH8 inhibitors target the active site of PCDH8, ensuring their specificity for this particular cell adhesion molecule. By inhibiting PCDH8, these compounds may disrupt the normal cell-cell adhesion patterns, which can have implications for processes like neuronal connectivity and circuit formation. The study of PCDH8 inhibitors is of significant interest to researchers as it provides insights into the regulatory mechanisms governing essential cellular functions in the nervous system. This knowledge contributes to our understanding of basic neurobiology and may have implications in various research areas, including neurodevelopment, synaptic plasticity, and neuronal connectivity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$96.00
$292.00
27
(1)

Inhibits Wnt processing and secretion by inhibiting Porcupine, indirectly affecting PCDH8.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor, alters cell signaling pathways potentially influencing PCDH8 activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor, affects MAPK/ERK pathway, which might indirectly modulate PCDH8.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, may impact signaling pathways indirectly influencing PCDH8 function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibits p38 MAPK, potentially affecting pathways related to PCDH8.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor, affects cell growth and survival pathways, potentially influencing PCDH8.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

γ-Secretase inhibitor, could indirectly affect PCDH8 by modulating Notch signaling.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor, potentially affects cytoskeletal dynamics related to PCDH8.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

V-ATPase inhibitor, can affect endosomal-lysosomal pathways, indirectly impacting PCDH8.

2-Methoxyestradiol

362-07-2sc-201371
sc-201371A
10 mg
50 mg
$71.00
$288.00
6
(1)

Disrupts microtubule dynamics, potentially affecting cellular processes related to PCDH8.